The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with mycobacterium tuberculosis

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Lachmandas, Ekta ^a   Vrieling, Frank ^b   Wilson, Louis G ^b   Joosten, Simone A ^b   Netea, Mihai G ^a   Ottenhoff, Tom H ^b   Van Crevel, Reinout ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN DERIVATIVE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIUM IDENTIFICATION; BLOOD LEVEL; CELL DIFFERENTIATION; CELL PHAGOCYTOSIS; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; GROWTH RATE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; MOLECULAR DYNAMICS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; TUBERCULOSIS; CANDIDA ALBICANS; IMMUNOLOGY; MACROPHAGE; MICROBIOLOGY; MIDDLE AGED; MONONUCLEAR CELL; NON INSULIN DEPENDENT DIABETES MELLITUS;

CANDIDA ALBICANS; MYCOBACTERIUM TUBERCULOSIS;

CANDIDA ALBICANS; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; INTERFERON-GAMMA; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MACROPHAGES; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922668887     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117941     Document Type: Article

References (37)

1. Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5: e152. doi: 10.1371/journal.pmed.0050152 PMID: 18630984
2. Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJ, van Crevel R (2010) Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health 15: 1289-1299. doi: 10.1111/j.1365-3156.2010.02625.x PMID: 20955495
3. th ed., Brussels, Belgium.
4. van CR, Dockrell HM (2014) TANDEM: understanding diabetes and tuberculosis. Lancet Diabetes Endocrinol 2: 270-272. doi: 10.1016/S2213-8587(14)70011-7 PMID: 24703039
5. Martinez N, Kornfeld H (2014) Diabetes and immunity to tuberculosis. Eur J Immunol 44: 617-626. doi: 10.1002/eji.201344301 PMID: 24448841
6. Ernst JD (2012) The immunological life cycle of tuberculosis. Nat Rev Immunol 12: 581-591. doi: 10. 1038/nri3259 PMID: 22790178
7. Ottenhoff TH (2012) New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol 20: 419-428. doi: 10.1016/j.tim.2012.06.002 PMID: 22784857
8. Jouanguy E, Lamhamedi-Cherradi S, Altare F, Fondaneche MC, Tuerlinckx D, et al. (1997) Partial inter-feron-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest 100: 2658-2664. PMID: 9389728
9. Harris J, Keane J (2010) How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin Exp Immunol 161: 1-9. doi: 10.1111/j.1365-2249.2010.04146.x PMID: 20491796
10. O 'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, et al. (2013) The immune response in tuberculosis. Annu Rev Immunol 31: 475-527. doi: 10.1146/annurev-immunol-032712-095939 PMID: 23516984
11. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH (2006) Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol 79: 285-293. PMID: 16330536
12. Redford PS, Boonstra A, Read S, Pitt J, Graham C, et al. (2010) Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur J Immunol 40: 2200-2210. doi: 10.1002/eji.201040433 PMID: 20518032
13. Gomez DI, Twahirwa M, Schlesinger LS, Restrepo BI (2013) Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control. Tuberculosis (Edinb) 93: 192-197. doi: 10.1016/j.tube.2012.10.003 PMID: 23131496
14. Lecube A, Pachon G, Petriz J, Hernandez C, Simo R (2011) Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One 6: e23366. doi: 10.1371/ journal.pone.0023366 PMID: 21876749
15. Sun C, Sun L, Ma H, Peng J, Zhen Y, et al. (2012) The phenotype and functional alterations of macrophages in mice with hyperglycemia for long term. J Cell Physiol 227: 1670-1679. doi: 10.1002/jcp. 22891 PMID: 21678423
16. Liu HF, Zhang HJ, Hu QX, Liu XY, Wang ZQ, et al. (2012) Altered polarization, morphology, and impaired innate immunity germane to resident peritoneal macrophages in mice with long-term type 2 diabetes. J Biomed Biotechnol 2012: 867023. doi: 10.1155/2012/867023 PMID: 23093868
17. Mo Y, Wan R, Wang J, Chien S, Tollerud DJ, et al. (2009) Diabetes is associated with increased sensitivity of alveolar macrophages to urban particulate matter exposure. Toxicology 262: 130-137. doi: 10. 1016/j.tox.2009.05.019 PMID: 19505525
18. Devaraj S, Venugopal SK, Singh U, Jialal I (2005) Hyperglycemia induces monocytic release of inter-leukin-6 via induction of protein kinase c-{alpha} and-{beta}. Diabetes 54: 85-91. PMID: 15616014
19. Restrepo BI, Fisher-Hoch SP, Pino PA, Salinas A, Rahbar MH, et al. (2008) Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47: 634-641. doi: 10.1086/590565 PMID: 18652554
20. Stalenhoef JE, Alisjahbana B, Nelwan EJ, van der VenJongekrijg V, Ottenhoff TH, et al. (2008) The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 27: 97-103. PMID: 17962984
21. Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Fay MP, et al. (2013) Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines. Ann Am Thorac Soc 10: 441-449. doi: 10.1513/AnnalsATS.201305-112OC PMID: 23987505
22. Atsma F, Veldhuizen I, de Vegt F, Doggen C, de KortW(2011) Cardiovascular and demographic characteristics in whole blood and plasma donors: results from the Donor InSight study. Transfusion 51: 412-420. doi: 10.1111/j.1537-2995.2010.02867.x PMID: 20804526
23. Leclerc L, Boudard D, Pourchez J, Forest V, Sabido O, et al. (2010) Quantification of microsized fluorescent particles phagocytosis to a better knowledge of toxicity mechanisms. Inhal Toxicol 22: 1091-1100. doi: 10.3109/08958378.2010.522781 PMID: 21047166
24. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, et al. (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 101: 4560-4565. PMID: 15070757
25. Tan KS, Lee KO, Low KC, Gamage AM, Liu Y, et al. (2012) Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest 122: 2289-2300. doi: 10. 1172/JCI57817 PMID: 22546856
26. Sugawara I, Mizuno S (2008) Higher susceptibility of type 1 diabetic rats to Mycobacterium tuberculosis infection. Tohoku J Exp Med 216: 363-370. PMID: 19060451
27. Sugawara I, Yamada H, Mizuno S (2004) Pulmonary tuberculosis in spontaneously diabetic goto kakizaki rats. Tohoku J Exp Med 204: 135-145. PMID: 15383694
28. Marhoffer W, Stein M, Maeser E, Federlin K (1992) Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 15: 256-260. PMID: 1547682
29. Komura T, Sakai Y, Honda M, Takamura T, Matsushima K, et al. (2010) CD14+ monocytes are vulnerable and functionally impaired under endoplasmic reticulum stress in patients with type 2 diabetes. Diabetes 59: 634-643. doi: 10.2337/db09-0659 PMID: 19959758
30. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, et al. (1997) Impaired leucocyte functions in diabetic patients. Diabet Med 14: 29-34. PMID: 9017350
31. Restrepo BI, Schlesinger LS (2013) Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis (Edinb) 93 Suppl: : S10-S14.
32. Restrepo BI, Twahirwa M, Rahbar MH, Schlesinger LS (2014) Phagocytosis via complement or Fcgamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia. PLoS One 9: e92977. doi: 10.1371/journal.pone.0092977 PMID: 24671137
33. Martens GW, Arikan MC, Lee J, Ren F, Greiner D, et al. (2007) Tuberculosis susceptibility of diabetic mice. Am J Respir Cell Mol Biol 37: 518-524. PMID: 17585110
34. Lardner A (2001) The effects of extracellular pH on immune function. J Leukoc Biol 69: 522-530. PMID: 11310837
35. Han JM, Patterson SJ, Speck M, Ehses JA, Levings MK (2014) Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity. J Immunol 192: 623-629. doi: 10.4049/jimmunol.1302181 PMID: 24323581
36. Tremaroli V, Backhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489: 242-249. doi: 10.1038/nature11552 PMID: 22972297
37. Mahajan S, Dkhar HK, Chandra V, Dave S, Nanduri R, et al. (2012) Mycobacterium tuberculosis modulates macrophage lipid-sensing nuclear receptors PPARgamma and TR4 for survival. J Immunol 188: 5593-5603. doi: 10.4049/jimmunol.1103038 PMID: 22544925